Stocks
Aurora Cannabis Financial Statements (ACB) |
||||||||||
| Aurora Cannabissmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.06.2020 | 30.06.2021 | 30.06.2022 | 31.03.2023 | 31.03.2024 | 31.03.2024 | ||||
| Currency | CAD | CAD | CAD | CAD | CAD | CAD | ||||
| Revenue, C$ | ? | 278 906 000 | 245 252 000 | 221 339 000 | 233 290 083 | 270 281 000 | 245 463 000 | |||
| Operating Income, C$ | -490 962 000 | -282 818 000 | -231 449 000 | -254 318 030 | -46 453 000 | -96 206 000 | ||||
| EBITDA, C$ | ? | -393 231 000 | -137 200 000 | -143 089 000 | -210 744 810 | 20 474 000 | -40 913 000 | |||
| Net profit, C$ | ? | -3 310 337 000 | -693 625 000 | -1 717 624 000 | -265 328 670 | -69 326 000 | -662 809 000 | |||
| OCF, C$ | ? | -337 952 000 | -210 577 000 | -109 838 000 | -115 821 000 | -68 508 000 | -83 914 000 | |||
| CAPEX, C$ | ? | 355 006 000 | 53 082 000 | 32 213 000 | 12 132 000 | 16 956 000 | 21 721 000 | |||
| FCF, C$ | ? | -692 958 000 | -263 659 000 | -142 051 000 | -127 953 000 | -85 464 000 | -105 635 000 | |||
| Dividend payout, C$ | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, C$ | 450 930 000 | 225 087 000 | 240 600 000 | 189 958 191 | 158 539 000 | 187 067 000 | ||||
| Cost of production, C$ | 312 445 000 | 266 810 000 | 200 114 000 | 297 649 922 | 138 821 000 | 135 654 000 | ||||
| R&D, C$ | 26 070 000 | 11 447 000 | 10 389 000 | 6 561 316 | 3 572 000 | 4 927 000 | ||||
| Interest expenses, C$ | 77 538 000 | 66 437 000 | 71 813 000 | 39 461 234 | 14 186 000 | 23 625 000 | ||||
| Assets, C$ | 2 783 695 000 | 2 604 731 000 | 1 084 356 000 | 926 322 000 | 838 673 000 | 838 673 000 | ||||
| Net Assets, C$ | ? | 2 150 806 000 | 2 037 700 000 | 661 843 000 | 486 076 000 | 559 773 000 | 559 773 000 | |||
| Debt, C$ | 531 247 000 | 399 550 000 | 269 491 000 | 227 522 000 | 104 791 000 | 104 791 000 | ||||
| Cash, C$ | 169 245 000 | 425 208 000 | 439 138 000 | 300 842 000 | 117 475 000 | 117 475 000 | ||||
| Net debt, C$ | 362 002 000 | -25 658 000 | -169 647 000 | -73 320 000 | -12 684 000 | -12 684 000 | ||||
| Ordinary share price, rub | 124.2 | 90.4 | 13.2 | 6.97 | 4.39 | 7.17 | ||||
| Number of ordinary shares, mln | 9 675 342 | 16 911 854 | 214 912 605 | 32 273 516 | 47 422 593 | 47 422 593 | ||||
| Market cap, C$ | 1 201 677 476 | 1 528 831 602 | 2 836 846 386 | 224 946 407 | 208 185 183 | 340 019 992 | ||||
| EV, C$ | ? | 1 563 679 476 | 1 503 173 602 | 2 667 199 386 | 151 626 407 | 195 501 183 | 327 335 992 | |||
| Book value, C$ | 810 107 000 | 782 515 000 | 591 147 000 | 405 958 000 | 475 743 000 | 475 743 000 | ||||
| EPS, rub | ? | -342.1 | -41.0 | -7.99 | -8.22 | -1.46 | -14.0 | |||
| FCF/share, rub | -71.6 | -15.6 | -0.66 | -3.96 | -1.80 | -2.23 | ||||
| BV/share, rub | 83.7 | 46.3 | 2.75 | 12.6 | 10.0 | 10.0 | ||||
| EBITDA margin, % | ? | -141.0% | -55.9% | -64.6% | -90.3% | 7.58% | -16.7% | |||
| Net margin, % | ? | -1 187% | -282.8% | -776.0% | -113.7% | -25.6% | -270.0% | |||
| FCF yield, % | ? | -57.7% | -17.2% | -5.01% | -56.9% | -41.1% | -31.1% | |||
| ROE, % | ? | -153.9% | -34.0% | -259.5% | -54.6% | -12.4% | -118.4% | |||
| ROA, % | ? | -118.9% | -26.6% | -158.4% | -28.6% | -8.27% | -79.0% | |||
| P/E | ? | -0.36 | -2.20 | -1.65 | -0.85 | -3.00 | -0.51 | |||
| P/FCF | -1.73 | -5.80 | -20.0 | -1.76 | -2.44 | -3.22 | ||||
| P/S | ? | 4.31 | 6.23 | 12.8 | 0.96 | 0.77 | 1.39 | |||
| P/BV | ? | 1.48 | 1.95 | 4.80 | 0.55 | 0.44 | 0.71 | |||
| EV/EBITDA | ? | -3.98 | -11.0 | -18.6 | -0.72 | 9.55 | -8.00 | |||
| Debt/EBITDA | -0.92 | 0.19 | 1.19 | 0.35 | -0.62 | 0.31 | ||||
| R&D/CAPEX, % | 7.34% | 21.6% | 32.3% | 54.1% | 21.1% | 22.7% | ||||
| CAPEX/Revenue, % | 127.3% | 21.6% | 14.6% | 5.20% | 6.27% | 8.85% | ||||
| Aurora Cannabis shareholders | ||||||||||
